Celldex Therapeutics Inc (CLDX) Cost of Revenue & History | Stock Alarm

Demo Sign up Log In

Celldex Therapeutics Inc · Cost of Revenue

CLDX Cost of Revenue

Latest reported$63.79Mperiod endingJun 30, 2026

CLDX Cost of Revenue (-$100.00K → $63.79M)

Annual cost of revenue

High-resolution chart · PNG

CLDX cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	0
Dec 31, 2024	163,550,000
Dec 31, 2023	118,011,000
Dec 31, 2022	82,258,000
Dec 31, 2021	53,311,000
Dec 31, 2020	42,534,000
Dec 31, 2019	42,672,000
Dec 31, 2018	66,449,000
Dec 31, 2017	96,171,000
Dec 31, 2016	102,026,000
Dec 31, 2015	4,011,000
Dec 31, 2014	3,401,000
Dec 31, 2013	2,334,000
Dec 31, 2012	10,775,000
Dec 31, 2011	9,119,000
Dec 31, 2010	12,077,000
Dec 31, 2009	8,397,000
Dec 31, 2008	0
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	41,000
Dec 31, 2001	36,800
Dec 31, 2000	-689,300
Dec 31, 1999	-712,800
Dec 31, 1998	-400,000
Dec 31, 1997	-300,000
Dec 31, 1996	-100,000
Dec 31, 1995	1,200,000
Dec 31, 1994	1,200,000
Dec 31, 1993	1,500,000
Dec 31, 1992	600,000
Apr 30, 1992	1,100,000
Apr 30, 1990	800,000
Apr 30, 1989	800,000
Apr 30, 1988	300,000
Apr 30, 1987	-100,000
Apr 30, 1986	-100,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.